arg-3-hyp-7-phe-bradykinin has been researched along with somatostatin in 4 studies
| Studies (arg-3-hyp-7-phe-bradykinin) | Trials (arg-3-hyp-7-phe-bradykinin) | Recent Studies (post-2010) (arg-3-hyp-7-phe-bradykinin) | Studies (somatostatin) | Trials (somatostatin) | Recent Studies (post-2010) (somatostatin) |
|---|---|---|---|---|---|
| 52 | 2 | 3 | 29 | 0 | 11 |
| Protein | Taxonomy | arg-3-hyp-7-phe-bradykinin (IC50) | somatostatin (IC50) |
|---|---|---|---|
| Somatostatin receptor type 5 | Mus musculus (house mouse) | 0.0001 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 0.01 | |
| Somatostatin receptor type 1 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 1 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 2 | Homo sapiens (human) | 0.0007 | |
| Somatostatin receptor type 2 | Mus musculus (house mouse) | 0.0002 | |
| Somatostatin receptor type 3 | Mus musculus (house mouse) | 0.0001 | |
| Somatostatin receptor type 5 | Rattus norvegicus (Norway rat) | 0.0009 | |
| Somatostatin receptor type 4 | Homo sapiens (human) | 0.0012 | |
| Somatostatin receptor type 3 | Homo sapiens (human) | 0.002 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.006 | |
| Somatostatin receptor type 5 | Homo sapiens (human) | 0.003 | |
| Somatostatin receptor type 4 | Mus musculus (house mouse) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
| Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
4 other study(ies) available for arg-3-hyp-7-phe-bradykinin and somatostatin
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |